Literature DB >> 20502767

Temporal bone pneumatization and its relationship to paranasal sinus development in cystic fibrosis.

Clarice M Seifert1, Richard J Harvey, Joe W Mathews, Ted A Meyer, Chadwick Ahn, Brad A Woodworth, Rodney J Schlosser.   

Abstract

BACKGROUND: There is significant debate on the influence of inflammatory mucosal disease on paranasal sinus pneumatization (PSP) and temporal bone pneumatization (TBP) in cystic fibrosis patients (CF). It is often assumed that mucosal disease of the paranasal sinuses will negatively influence development and pneumotization of the paranasal sinuses and temporal bone system.
METHODS: A case-control study of TBP and PSP in CF, chronic rhinosinusitis (CRS) and healthy control patients from a tertiary rhinology clinic. TBP and PSP were assessed by computed tomography (CT) using a previously validated scale. Genotype data for patients with CF was determined.
RESULTS: In total, 186 temporal bones and paranasal sinuses from 93 adult patients were assessed through evaluation of CT scans. Tha patients had a mean age of 43.4 +/- 14.9 yrs. The interobserver correlation for TB scoring was 0.86. TBP did not differ between CF, CRS and controls (chi(2) = 6.93, p = 0.38). PSP was less in the CF group (chi(2) = 34.2, p < 0.001) than the CRS and control groups. CRS and controls did not differ in PSP. 51.6% of CF patients were homozygous for DeltaF508 and 16.1% were heterozygous. The DeltaF508 status correlated with poorer SP (chi(2) = 34.2, p < 0.001), but greater TBP (chi(2) = 14.9, p = 0.002)
CONCLUSIONS: PSP is impaired in CF and DeltaF508 homozygosity is related to poor PSP. TBP is well preserved in the CF population and DeltaF508 homozygosity correlates with greater TBP, with the underlying mechanisms being unclear. Genotype might play a role in skull base pneumatization.

Entities:  

Mesh:

Year:  2010        PMID: 20502767     DOI: 10.4193/Rhin09.145

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  6 in total

Review 1.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

2.  Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis.

Authors:  Suzie Hyeona Kang; Camila Degen Meotti; Karine Bombardelli; Otávio Bejzman Piltcher; Paulo de Tarso Roth Dalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-18       Impact factor: 2.503

Review 3.  Epidemiology and differential diagnosis of nasal polyps.

Authors:  Mohamad R Chaaban; Erika M Walsh; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Nov-Dec       Impact factor: 2.467

4.  Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.

Authors:  Chelsea M Blankenship; Lisa L Hunter; M Patrick Feeney; Madison Cox; Lindsey Bittinger; Angela C Garinis; Li Lin; Gary McPhail; John P Clancy
Journal:  Am J Audiol       Date:  2021-01-19       Impact factor: 1.636

5.  Variability of Paranasal Sinus Pneumatization in the Absence of Sinus Disease.

Authors:  Michael J Marino; Charles A Riley; Eric L Wu; Jacqueline E Weinstein; Noah Emerson; Edward D McCoul
Journal:  Ochsner J       Date:  2020

6.  Otitis media prone children with cystic fibrosis: A new normal.

Authors:  Jennifer L McCoy; Thomas M Kaffenberger; Tiffany S Yang; Joseph E Dohar
Journal:  Am J Otolaryngol       Date:  2021-06-19       Impact factor: 2.873

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.